Longevity research network, Rejuve.AI reveals its first app, Longevity, which combines Artificial Intelligence (AI), world-leading research, and blockchain technology to drive breakthroughs in human life extension. In a first for the industry, Longevity will give users full control over their health data as part of its mission to democratise and advance longevity science breakthroughs that were previously inaccessible beyond the realms of academia or significant wealth.

Latest Aithority Insights: AiThority.com to Attend The Character of AI – A Technology Ethics Conference (Virtual)

The app uniquely uses AI to pull findings from 100s of scientific studies on ageing to give users insight into their current risk rating, the nine hallmarks of ageing plus an additional proposed tenth hallmark, and health recommendations around factors such as weight, sleep, physical exercise, lifestyle, and diet. This not only gives users a live record of their personal health, but also allows them access to the latest breakthroughs in longevity research.

Underpinned by SingularityNET’s AI, which powers the brain of Hanson Robotics’ Sophia the Robot (the world’s first robot citizen), the Longevity app will bring innovative and comprehensive features, tools, and products to the market, including personalised health recommendations and insights, biological age estimation, health surveys, health trackers, blood test data, and rewards.

The app is designed to put power back into the hands of its users by ensuring they receive a fair share of proceeds gained from the use of their data. Users will be able to securely contribute personal medical, biological, and lifestyle data to a database that provides members personalised health recommendations insights. In exchange for this contribution, users will also receive Rejuve (RJV) tokens, which they can use to purchase supplements, longevity clinic services and spas, wearables and medical and DNA tests. This data gathered by the app, will then be anonymized and encrypted and used by a network of researchers to discover new longevity therapies.